loading

Alnylam Pharmaceuticals Inc (ALNY) 재무 분석

손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
기간 3개월 3개월 3개월 3개월 3개월
Revenues
12.17%
1,097.03
1,249.03 773.69 594.19 593.17
Cost Of Revenue
35.74%
267.72
197.23 142.03 70.18 102.65
Gross Profit
21.15%
829.31
1,051.80 631.66 524.01 490.52
Operating Expenses
2.02%
697.59
683.81 647.86 505.93 595.68
Benefits Costs and Expenses
7.34%
935.90
1,010.06 809.05 635.78 787.12
Costs And Expenses
9.56%
965.32
881.04 789.89 576.11 698.33
Operating Income/Loss
64.21%
131.72
367.98 -16.20 18.08 -105.16
Nonoperating Income/Loss
64.77%
-45.46
-129.01 -19.16 -20.45 -88.80
Income/Loss From Continuing Operations Before Tax
63.90%
86.26
238.97 -35.36 -2.368 -193.96
Income Tax Expense/Benefit, Deferred
585.35%
-27.17
5.598 9.735 9.639 -
Income Tax Expense/Benefit
108.68%
-25.28
-12.12 30.92 15.88 -110.19
Income/Loss From Continuing Operations After Tax
69.39%
76.86
251.08 -66.28 -2.368 -83.76
Net Income/Loss
55.58%
111.54
251.08 -66.28 -18.25 -83.76
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
99.69%
0.414
131.45 130.63 129.68 0.492
Diluted Average Shares
99.61%
0.538
137.35 130.63 129.68 0.492
Basic Earnings Per Share
56.02%
0.84
1.91 -0.51 -0.14 -0.65
Diluted Earnings Per Share
55.43%
0.82
1.84 -0.51 -0.14 -0.65
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$707.26
price up icon 0.81%
biotechnology ONC
$289.99
price up icon 1.21%
$143.89
price up icon 2.37%
$92.77
price up icon 1.57%
$53.10
price up icon 1.58%
자본화:     |  볼륨(24시간):